{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:59:43Z","timestamp":1773280783717,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.006","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T20:21:42Z","timestamp":1532722902000},"page":"2781-2791","source":"Crossref","is-referenced-by-count":18,"title":["Is Management of Central Retinal Artery Occlusion the Next Frontier in Cerebrovascular Diseases?"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-7407","authenticated-orcid":false,"given":"Kaustubh","family":"Limaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Uwaydat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheharayar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Al Kasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2459-3395","authenticated-orcid":false,"suffix":"Jr","given":"Harold","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0001","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-4835(05)80121-6","article-title":"The 1994 Von Sallman Lecture: the optic nerve head circulation in health and disease","volume":"61","author":"Hayreh","year":"1995","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/brain\/91.3.419","article-title":"The natural history of amaurosis fugax","volume":"91","author":"Marshall","year":"1968","journal-title":"Brain"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/WNL.9.5.333","article-title":"Observations of the fundus oculi in transient monocular blindness","volume":"9","author":"Fisher","year":"1959","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.1961.03040400025005","article-title":"Significance of bright plaques in the retinal arteries","volume":"173","author":"Hollenhorst","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(68)92453-7","article-title":"The source of retinalemboli","volume":"2","author":"Russell","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0006","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3171\/jns.1965.23.4.0400","article-title":"Clinical evaluation of artificial embolization in the management of large cerebral arteriovenous malformation","volume":"23","author":"Luessenhop","year":"1965","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0007","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9394(74)90022-1","article-title":"Clinical-angiographic correlations in amaurosis fugax","volume":"78","author":"Sandok","year":"1974","journal-title":"Am J Ophthal"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0008","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.STR.6.5.493","article-title":"Amaurosis fugax: a clinical comparison","volume":"6","author":"Slepyan","year":"1975","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0009","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM199811123392002","article-title":"Benefit of carotid endar- terectomy in symptomatic patients with moderate and severe stenosis","volume":"339","author":"Barnett","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0010","doi-asserted-by":"crossref","unstructured":"Randomised trial of carotid endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.","DOI":"10.1016\/S0140-6736(97)09292-1"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0011","doi-asserted-by":"crossref","unstructured":"North American Symptomatic Carotid Endarterectomy Trial: methods, patient characteristics, and progress. Stroke 1991;22:711-720.","DOI":"10.1161\/01.STR.22.6.711"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF02720764","article-title":"Ueber Embolie der Arteria centralis retinae als Ursache plotzlicher Erblindung","volume":"5","author":"Von Graefe","year":"1859","journal-title":"Albrecht Graefes Arch Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/bjo.44.4.193","article-title":"The central artery of the retina I. Origin and course","volume":"44","author":"Singh","year":"1960","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0014","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0008-4182(00)80125-8","article-title":"Characteristics of patients presenting with central retinal artery occlusion with and without giant cell arteritis","volume":"35","author":"Connolly","year":"2000","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0015","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1212\/WNL.0b013e3181eb58de","article-title":"Teaching NeuroImages: central retinal artery occlusion with cilioretinal artery sparing in giant cell arteritis","volume":"75","author":"Cohen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0016","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.41.10.1698","article-title":"Central retinal artery occlusion in giant cell arteritis Treatment with nitroglycerin","volume":"41","author":"Charness","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0017","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0161-6420(92)31777-4","article-title":"IV steroids for central retinal artery occlusion in giant-cell arteritis","volume":"99","author":"Clearkin","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0018","series-title":"A Study of the Central Artery of the Retina in Human Beings in its Intra-orbital and Intra-neural Course","author":"Hayreh","year":"1958"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2011.05.001","article-title":"Acute retinal arterial occlusive disorders","author":"Hayreh","year":"2011","journal-title":"Progr Retin Eye Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.preteyeres.2004.12.001","article-title":"Prevalent misconceptions about acute retinal vascular occlusive disorders","volume":"24","author":"Hayreh","year":"2005","journal-title":"Progr Retin Eye Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0021","first-page":"351","article-title":"The natural history of patients with amau-rosis fugax","volume":"9","author":"Kline","year":"1996","journal-title":"Ophthalmol Clin NA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0022","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2015.05.044","article-title":"Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination","volume":"122","author":"Callizo","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajo.2005.03.038","article-title":"Central retinal artery occlusion: visual outcome","volume":"140","author":"Hayreh","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0024","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2009.06.008","article-title":"Treatment of nonarteritic anterior ischemic optic neuropathy","volume":"55","author":"Atkins","year":"2010","journal-title":"Survey Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.iae.0000238095.97104.9b","article-title":"Fundus changes in central retinal artery occlusion","volume":"27","author":"Hayreh","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0026","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0741-5214(86)90169-2","article-title":"The clinical significance of the asymptomatic Hollenhorst plaque","volume":"4","author":"Bunt","year":"1986","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0027","first-page":"17","article-title":"Is carotid ultrasound necessary in the clinical evaluation of the asymptomatic Hollenhorst plaque?(An American Ophthalmological Society thesis)","volume":"111","author":"Bakri","year":"2013","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0028","first-page":"140","article-title":"The treatment of giant cell arteritis","volume":"5","author":"Fraser","year":"2008","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0161-6420(81)35080-5","article-title":"Retinal arterial obstruction in children and young adults","volume":"88","author":"Brown","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0030","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0031","doi-asserted-by":"crossref","first-page":"e44959","DOI":"10.1371\/journal.pone.0044959","article-title":"Clues to occult cancer in patients with ischemic stroke","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0032","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00000658-198807000-00012","article-title":"The association of central retinal artery occlusion and extracranial carotid artery disease","volume":"208","author":"Douglas","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archneur.1975.00490430027003","article-title":"Transient ischemic attacks due to atherosclerosis. A prospective study of 160 patients","volume":"32","author":"Toole","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0034","first-page":"864","article-title":"Carotid duplex scan versus angiography in evaluation of carotif artery disease","volume":"60","author":"Fontenelle","year":"1994","journal-title":"Am Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7863\/jum.1985.4.5.239","article-title":"Duplex carotid sonography: correlation with digital subtraction angiography and conventional angiography","volume":"4","author":"Jackson","year":"1985","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0036","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1148\/rg.256045013","article-title":"Sonographic examination of the carotid arteries","volume":"25","author":"Tahmasebpour","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0037","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0741-5214(89)90471-0","article-title":"The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries","volume":"9","author":"Langsfeld","year":"1989","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0038","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0741-5214(93)90020-M","article-title":"The natural history of asymptomatic carotid artery disease","volume":"17","author":"Bock","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0039","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/STROKEAHA.110.589754","article-title":"Carotid plaque area and intima-media thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Troms\u00d8 study","volume":"42","author":"Mathiesen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0040","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/hs1001.096613","article-title":"Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice","volume":"32","author":"Qureshi","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0041","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0035-1556056","article-title":"Multimodality imaging of carotid stenosis","volume":"24","author":"Adla","year":"2015","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0042","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1552-6569.2002.tb00124.x","article-title":"Echocardiographic findings of patients with retinal ischemia or embolism","volume":"12","author":"Mouradian","year":"2002","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0043","first-page":"38","article-title":"Transthoracic echocardiography in young patients with acute retinal arterial obstruction. RECO Study Group. Retinal Emboli of Cardiac Origin Group","volume":"32","author":"Sharma","year":"1997","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11940-012-0202-9","article-title":"Treatment options for central retinal artery occlusion","volume":"15","author":"Cugati","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/eye.2013.25","volume":"27","author":"Varma","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0046","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0014-4835(03)00214-8","article-title":"Central retinal artery occlusion: retinal survival time","volume":"78","author":"Hayreh","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0047","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0161-6420(80)35283-4","article-title":"Central retinal artery occlusion and retinal tolerance time","volume":"87","author":"Hayreh","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0048","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0049","first-page":"287","article-title":"Treatment of patients suffering from early, myocardial infarction with massive and prolonged streptokinase therapy","volume":"71","author":"Fletcher","year":"1958","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0050","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJM198312153092402","article-title":"Western Wash- ington randomized trial of intracoronary streptokinase in acute myocardial infarction","volume":"309","author":"Kennedy","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0051","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myo- cardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0052","first-page":"2849","article-title":"Immediate versus delayed catheteriza- tion and angioplasty after thrombolytic therapy for acute myocardial infarction","volume":"260","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0053","doi-asserted-by":"crossref","unstructured":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of rete- plase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337:1118-1123","DOI":"10.1056\/NEJM199710163371603"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0054","doi-asserted-by":"crossref","unstructured":"Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. N Engl J Med. 1995;333:1581-1587.","DOI":"10.1056\/NEJM199512143332401"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1747-4949.2012.00910.x","article-title":"The Desmoteplase in Acute Ischemic Stroke (DIAS) clinical trial program","volume":"7","author":"Von Kummer","year":"2012","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0056","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0057","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001989","article-title":"Interventions for acute non-arteritic central retinal artery occlusion","volume":"1","author":"Fraser","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0059","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0161-6420(99)90165-3","article-title":"Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator","volume":"106","author":"Richard","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9394(99)00359-1","article-title":"Aggressive systematic treatment for central retinal artery occlusion","volume":"128","author":"Rumelt","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0061","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","article-title":"Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion","volume":"42","author":"Chen","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0062","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","article-title":"Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial","volume":"117","author":"Schumacher","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0063","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/STROKEAHA.107.505404","article-title":"Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion","volume":"39","author":"Aldrich","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0064","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","article-title":"Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion","volume":"146","author":"Hattenbach","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/01.STR.0000251720.25337.b0","article-title":"Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?","volume":"38","author":"Shaltoni","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0066","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00415-017-8702-x","article-title":"Current treatment of central retinal artery occlusion: a national survey","volume":"265","author":"Youn","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0067","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/S0161-6420(95)30758-0","article-title":"Efficacy of anterior chamber paracentesis and Carbogen in treating acute nonarteritic central retinal artery occlusion","volume":"102","author":"Atebara","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0068","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/archopht.1983.01040020280023","article-title":"Effects of oxygen and carbon dioxide on the retinal vasculature in humans","volume":"101","author":"Deutsch","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0069","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/eye.1993.159","article-title":"The effect of acetazolamide on the retinal circulation","volume":"7","author":"Rassam","year":"1993","journal-title":"Eye"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00055735-200306000-00005","article-title":"Update on treatment of retinal arterial occlusions","volume":"14","author":"Rumelt","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0071","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002128.pub4","article-title":"Dietary advice for reducing cardiovascular risk","volume":"12","author":"Rees","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0072","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.0000000000003534","article-title":"Relationship between risk factor control and vascular events in the SAMMPRIS trial","volume":"88","author":"Turan","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0073","doi-asserted-by":"crossref","unstructured":"Sami Al Kasab, Chirantan Banerjee, Michael Lynn, et\u00a0al. Tolerability and medication requirements of aggressive medical management in SAMMPRIS Stroke. 2017;48:A2","DOI":"10.1161\/str.48.suppl_1.2"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0074","article-title":"Relationship between risk factor control and compliance with a lifestyle modification program in the stenting aggressive medical management for prevention of recurrent stroke in intracranial stenosis trial","author":"Turan","year":"2017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/eye.2009.142","article-title":"Vascular risk factors for central retinal artery occlusion","volume":"24","author":"Rudkin","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0076","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0077","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0078","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0079","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"LIFE Study Group Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0080","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0081","doi-asserted-by":"crossref","unstructured":"Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES),\u201d Stroke, vol. 36, no. 6, pp. 1218-1224, 2005","DOI":"10.1161\/01.STR.0000166048.35740.a9"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0082","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0083","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0084","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0085","doi-asserted-by":"crossref","unstructured":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study group. N Engl J Med. 1998;339:1349-1357.","DOI":"10.1056\/NEJM199811053391902"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0086","doi-asserted-by":"crossref","unstructured":"The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.","DOI":"10.1056\/NEJMoa061894"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0087","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.59.1.8","article-title":"Diabetes and cardiovascular risk factors: the Framingham study","volume":"59","author":"Kannel","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0088","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","article-title":"Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes?","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0089","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular compli- cations of diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0090","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glu- cose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0091","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0092","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0093","doi-asserted-by":"crossref","unstructured":"Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke, Stroke, vol. 37, no. 6, pp. 1413-1417, 2006.","DOI":"10.1161\/01.STR.0000221766.73692.0b"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0094","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0095","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and carotid endarterectomy (ACE) trial collaborators","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0096","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0097","doi-asserted-by":"crossref","unstructured":"Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin,\u201d Stroke, vol. 34, no. 1, pp. 234-235, 2003.","DOI":"10.1161\/01.STR.0000047035.04395.ED"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0098","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjophthalmol-2013-304316","article-title":"An audit of management practices in patients with suspected temporary monocular blindness","volume":"98","author":"Naylor","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0099","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0912321","article-title":"Stenting versus endarterectomy for treatment of carotid-artery stenosis","volume":"363","author":"Brott","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0100","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505215","article-title":"Long-term results of stenting versus endarterectomy for carotid-artery stenosis","volume":"374","author":"Brott","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.06.006_bib0101","doi-asserted-by":"crossref","first-page":"P120","DOI":"10.1016\/j.ophtha.2016.09.024","article-title":"Retinal and ophthalmic artery occlusions preferred practice pattern\u00ae","volume":"124","author":"Olsen","year":"2017","journal-title":"Ophthalmology"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718303215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718303215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T10:01:08Z","timestamp":1661680868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718303215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1052305718303215"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.06.006","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}